Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanolamine oleate sclerotherapy concentration study for oral vascular anomalies
RBR-9xcx69Completed
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ethanolamine oleate in Oral vascular anomaly (3 arms), sponsored by Universidade Federal de Minas Gerais. Primary endpoint: Clinical healing of lesion. Started Apr 2014; status: completed.
02
Drugs
ethanolamine oleate
03
Conditions
Oral vascular anomaly
Beyond the preview
Go deeper on RBR-9xcx69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9xcx69.